Skip to main content
Virbac logo

Virbac — Investor Relations & Filings

Ticker · FR000 ISIN · FR0000031577 LEI · 969500QQ1X5XHG649644 PA Manufacturing
Filings indexed 975 across all filing types
Latest filing 2023-10-06 Report Publication Anno…
Country FR France
Listing PA FR000

Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Founded in 1968 by a veterinarian, the company provides veterinarians, farmers, and pet owners with a comprehensive range of products and services. Its portfolio of innovative solutions covers the majority of animal species and diseases, with a focus on both companion and farm animals. Key product areas include vaccines, dermatology, parasite control, dental care, nutrition, and diagnostics. Through its international R&D network, Virbac develops solutions to prevent, diagnose, and treat animal pathologies, contributing to animal welfare and supporting sustainable farming.

Recent filings

Filing Released Lang Actions
Virbac : Communiqué de mise à disposition du rapport financier semestriel au 30 juin 2023.
Report Publication Announcement Classification · 99% confidence The document text is very short (434 characters) and explicitly states that the 'rapport financier semestriel' (half-year financial report) for June 30, 2023, has been made available to the public and filed with the AMF (Autorité des marchés financiers). The text focuses entirely on announcing the availability of the report and where to find it, rather than containing the report's content itself. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating a report has been published points to a Report Publication Announcement (RPA). This is a stronger fit than the general Regulatory Filing (RNS) because RPA specifically covers announcements about the publication of reports.
2023-10-06 French
VIRBAC: MAR Rapport Hebdomadaire_VIRBAC SA_25 au 29 Septembre 2023
Transaction in Own Shares Classification · 100% confidence The document title is "Déclaration des transactions sur actions propres réalisées du 25/09/2023 au 29/09/2023" (Declaration of transactions on own shares carried out from 09/25/2023 to 09/29/2023). The content consists of detailed tables listing daily transactions (volume, price, market) related to the company's own shares. This directly corresponds to the definition of a report detailing the company buying back or selling its own shares. The appropriate code is POS (Transaction in Own Shares).
2023-10-02 French
VIRBAC: MAR Weekly Report_VIRBAC SA_25 to 29 September 2023
Transaction in Own Shares Classification · 100% confidence The document explicitly details 'Statement of transactions in own shares' covering a specific period (September 25, 2023 to September 29, 2023). It provides aggregated daily volume and detailed transaction logs, including price, volume, and market codes, related to the issuer (VIRBAC SA) trading its own stock. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase or issuance activities.
2023-10-02 English
VIRBAC: résultat opérationnel courant avant R&D du premier semestre 2023 en légère amélioration en pourcentage du chiffre d'affaires
Earnings Release Classification · 99% confidence The document is titled with financial highlights for the 'premier semestre 2023' (first half of 2023) and presents consolidated figures (Revenue, Operating Income, Net Income) comparing 2023 to 2022. It explicitly mentions that the accounts were reviewed by the board and the auditors' report is being issued ('Le rapport des commissaires aux comptes est en cours d'émission'). It also states that the detailed presentation of the semi-annual results will be available later. Crucially, the document is a press release announcing the results for a period shorter than a year (six months). This strongly indicates an Interim/Quarterly Report (IR). It is not a full Annual Report (10-K), nor is it just a brief announcement of a report's publication (RPA), as it contains substantial financial data and management commentary. It is also not a Call Transcript (CT) or a formal Investor Presentation (IP), but rather the initial release of the period's performance. H1 2023
2023-09-28 French
VIRBAC: current operating income before R&D slightly improving throughout first half of 2023 in percentage of revenue
Earnings Release Classification · 98% confidence The document is explicitly labeled as a "Press release issued on September 28, 2023 after market close" and contains consolidated financial figures for the period ending June 30, 2023, comparing them to 2022. It details revenue, operating income, net income, and cash flow for the first half of the year. This structure is characteristic of an Earnings Release (ER), which provides the initial announcement of periodical financial results (key highlights). Although it mentions that detailed presentations will be available later, the document itself is the primary release of the half-year results, making 'ER' the most appropriate classification over 'RPA' or 'IR' (which is usually more comprehensive). H1 2023
2023-09-28 English
MAR Rapport Hebdomadaire_VIRBAC SA_18 au 22 septembre 2023
Transaction in Own Shares Classification · 100% confidence The document title is "Déclaration des transactions sur actions propres réalisées du 18/09/2023 au 22/09/2023" (Declaration of transactions on own shares carried out from 09/18/2023 to 09/22/2023). The content consists of detailed tables listing transactions involving the purchase/sale of the company's own shares ('Volume total journalier (en nombre d'actions)', 'Prix pondéré moyen journalier d'acquisition des actions', and 'Quantité achetée'). This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). Therefore, the appropriate filing type code is POS.
2023-09-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.